These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9875877)

  • 1. Serogroup Y meningococcal disease in Chicago, 1991-1997.
    Racoosin JA; Whitney CG; Conover CS; Diaz PS
    JAMA; 1998 Dec 23-30; 280(24):2094-8. PubMed ID: 9875877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991.
    Jackson LA; Wenger JD
    MMWR CDC Surveill Summ; 1993 Jun; 42(2):21-30. PubMed ID: 8510639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
    Diermayer M; Hedberg K; Hoesly F; Fischer M; Perkins B; Reeves M; Fleming D
    JAMA; 1999 Apr; 281(16):1493-7. PubMed ID: 10227318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1010-3. PubMed ID: 8965799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13.
    Neri A; Pezzotti P; Fazio C; Vacca P; D'Ancona FP; Caporali MG; Stefanelli P
    PLoS One; 2015; 10(10):e0139376. PubMed ID: 26445461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual report of the Australian Meningococcal Surveillance Programme, 2011.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2012 Sep; 36(3):E251-62. PubMed ID: 23186236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.
    MacNeil JR; Blain AE; Wang X; Cohn AC
    Clin Infect Dis; 2018 Apr; 66(8):1276-1281. PubMed ID: 29126310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.
    Knol MJ; Hahné SJM; Lucidarme J; Campbell H; de Melker HE; Gray SJ; Borrow R; Ladhani SN; Ramsay ME; van der Ende A
    Lancet Public Health; 2017 Oct; 2(10):e473-e482. PubMed ID: 29253430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease due to serogroup Y in Scotland, 1992-1999.
    Clarke SC; Reid J; Thom L; Denham BC; Edwards GF
    Br J Biomed Sci; 2001; 58(1):17-9. PubMed ID: 11284218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure.
    Wang X; Shutt KA; Vuong JT; Cohn A; MacNeil J; Schmink S; Plikaytis B; Messonnier NE; Harrison LH; Clark TA; Mayer LW
    J Infect Dis; 2015 Jun; 211(12):1887-94. PubMed ID: 25556253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing epidemiology of meningococcal disease in the United States, 1992-1996.
    Rosenstein NE; Perkins BA; Stephens DS; Lefkowitz L; Cartter ML; Danila R; Cieslak P; Shutt KA; Popovic T; Schuchat A; Harrison LH; Reingold AL
    J Infect Dis; 1999 Dec; 180(6):1894-901. PubMed ID: 10558946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005.
    du Plessis M; von Gottberg A; Cohen C; de Gouveia L; Klugman KP;
    J Clin Microbiol; 2008 Oct; 46(10):3208-14. PubMed ID: 18650361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australian Meningococcal Surveillance Programme annual report, 2014.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E221-8. PubMed ID: 27522133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.
    De Wals P; De Serres G; Niyonsenga T
    JAMA; 2001 Jan; 285(2):177-81. PubMed ID: 11176810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique.
    Ibarz-Pavón AB; Morais L; Sigaúque B; Mandomando I; Bassat Q; Nhacolo A; Quintó L; Soriano-Gabarró M; Alonso PL; Roca A
    PLoS One; 2011; 6(6):e19717. PubMed ID: 21695194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of invasive Neisseria meningitidis with a serogroup Y update, Sweden 2010 to 2012.
    Törös B; Thulin Hedberg S; Jacobsson S; Fredlund H; Olcén P; Mölling P
    Euro Surveill; 2014 Oct; 19(42):. PubMed ID: 25358044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serogroup C meningococcal outbreaks in the United States. An emerging threat.
    Jackson LA; Schuchat A; Reeves MW; Wenger JD
    JAMA; 1995 Feb; 273(5):383-9. PubMed ID: 7823383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disease burden of invasive meningococcal serogroup B disease in Canada.
    Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
    Pediatr Infect Dis J; 2013 Jan; 32(1):e20-5. PubMed ID: 22926207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.